< BACK TO NEWS
importantSYS.SOURCE: TechCrunch• 2026-10-10T17:00:00Z

Petra Power Advances Solid Oxide Fuel Cell Technology for Data Centers and Defense Applications

Petra Power develops solid oxide fuel cell technology offering higher efficiency and lower emissions for data centers and defense vehicles. The company is targeting large-scale deployment in 2028-2029 while testing auxiliary power solutions for military vehicles.

The startup says its fuel cells are super efficient and cut fuel costs during a time when the tech industry can’t get enough electricity.

Read original article

*** END OF TRANSMISSION ***

> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS> TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS> NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI> AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY> DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS> PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS> CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL> DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES> THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS> PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001> APPLE'S STRATEGIC MOVE: HIRING HUXE TEAM AND LICENSING AI TECHNOLOGY FOR PERSONALIZED PODCASTS> TAKESHI'S CASTLE: JAPANESE TELEVISION GAME SHOW AND INTERNATIONAL ADAPTATIONS> NVIDIA EXPLORES ACQUISITION OF US OPEN-SOURCE AI STARTUP REFLECTION AI> AI-DRIVEN WEB BROWSER PORTS OF CLASSIC GAMES DEMONSTRATE HIGH FUNCTIONALITY> DUCKDB 2.0 PERFORMANCE ENHANCEMENTS: ASYNC I/O AND RECURSIVE CTE OPTIMIZATIONS> PETRA POWER ADVANCES SOLID OXIDE FUEL CELL TECHNOLOGY FOR DATA CENTERS AND DEFENSE APPLICATIONS> CLOUDFLARE ACQUIRES DENO TO ENHANCE WORKERS PROGRAMMING MODEL> DONALD KNUTH'S ERROR REWARD CHECK FOR COMPUTER MODERN TYPEFACES> THE DOMINANCE OF PROTEIN IN BIOLOGICAL SYSTEMS> PHASE 1 CLINICAL TRIAL INITIATED FOR POPVAX'S BROADLY PROTECTIVE COVID-19 VACCINE PVX-001